Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: Plasmid versus cell line dilutions

Annals of Oncology

Volumn 14, Issue 8, 2003, Pages 1241-1245

  Saad Ismail, M ^a,b   Wynendaele, W ^a   Aerts, J L E ^a   Paridaens, Robert ^a   Van Mellaert, L ^c   Anne J ^c   Gaafar, R ^b   Shakankiry, N ^b   Khaled, H M ^b   Christiaens, M R ^a   Omar, S ^b   Vandekerckhove, P ^a   van Oosterom, A T ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Breast cancer; Cytokeratin 19; Plasmid dilutions; Quantitative RT PCR

Indexed keywords

CYTOKERATIN 19;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CARCINOMA CELL; CELL LINE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOLECULAR CLONING; PLASMID; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANK SUM TEST; REFERENCE VALUE; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; TUMOR CELL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INDICATOR DILUTION TECHNIQUES; KERATINS; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; PLASMIDS; PROBABILITY; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED;

EID: 0043011553     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg341     Document Type: Article

References (14)

1. Diel IJ, Kaufmann M, Costa SD et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996; 88: 1652-1658.
2. Braun S, Pantel K, Muller P et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000; 342: 525-533.
3. Fields KK, Elfenbein GJ, Trudeau WL et al. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996; 14: 1868-1876.
4. Aerts J, Wynendaele W, Paridaens R et al. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol 2001; 12: 39-46.
5. Saad Ismail M, Wynendaele W, Aerts J et al. Quantification of CK19 mRNA in peripheral blood (PB) and bone marrow (BM) from primary operable breast cancer (BC) patients pre- and postoperatively to investigate possible shedding of CK19+ cells during the operation. Proceedings of ECCO-11. Eur J Cancer 2001; 37 (Suppl 6):S117.
6. Stathopoulou A, Vlachonikolis I, Mavroudis D et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 2002; 20: 3404-3412.
7. Hochhaus A, Weisser A, La Rosee P et al. Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia 2000; 14: 998-1005.
8. Smith BM, Slade MJ, English J et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol 2000; 18: 1432-1439.
9. Braun S, Pantel K. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients. Oncologist 2001; 6: 125-132.
10. Hawes D, Munro Neville A, Cote RJ. Occult metastasis. Biomed Pharmacother 2001; 55: 229-242.
11. Slade MJ, Smith BM, Sinnett HD et al. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999; 17: 870-879.
12. Ikeda N, Miyoshi Y, Motomura K et al. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA. Jpn J Cancer Res 2000; 91: 918-924.
13. Bieche I, Nogues C, Paradis V et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000; 6: 452-459.
14. Shammas FV, Deak E, Nysted A et al. Serial quantitative PCR analysis of bone marrow samples from breast cancer patients to monitor systemic micrometastases. Anticancer Res 2001; 21: 2099-2106.